Monthly Archives: March 2010
Patient Surveillance After Ovarian Cancer Treatment Is Variable: Presented at SSO
New data indicate that there is marked variability in the intensity of patient surveillance after curative-intent treatment for ovarian cancer. The results were released here on March 6 at the 2010 Society of Surgical Oncology Annual Cancer Symposium (SSO). Garo … Continue reading
New Test to See if Ovarian Cancer Masses are Cancerous (Wall Street Journal)
Written by Laura Johannes Doctors and hospitals are getting a new test that many think will help fight ovarian cancer, one of the deadliest cancers, by helping them to more quickly distinguish cancerous from benign growths. The test, which is … Continue reading
Chris’ Story
Every year over 21,000 women are diagnosed with ovarian cancer and 15,000 succumb to the disease. The powerful and emotional stories of these women and their families remind us of why we do what we do – work to save … Continue reading
Posted in Blog Leave a comment
Jami Myers
I am a nine year survivor of stage IIB ovarian cancer. When I was diagnosed my mother was in her ninth year battling the disease. I was one of the fortunate ones who had a doctor that was paying attention … Continue reading
Posted in Personal stories Leave a comment
Carrie Plemmons
My name is Carrie and I am a survivor of ovarian cancer. It all started when I was pregnant with my first and only child. I went through 14 hrs of labor and the lil’ guy didn’t want to come … Continue reading
Posted in Personal stories Leave a comment
Diana Curry
My mom, Diana, was diagnosed with IIIC ovarian cancer in May 1995. Like so many at this time she was misdiagnosed and the cancer was found by accident. The doctors determined her problem was her gallbladder, a “simple” in and … Continue reading
Posted in Mothers We Love, Personal stories Leave a comment
Prediagnosis Food Patterns Are Associated with Length of Survival from Epithelial Ovarian Cancer (J.ADA)
Abstract Background Dietary factors have been the focus of many studies on the etiology of ovarian cancer and may potentially affect survival. Indeed, three recent studies outside the United States have suggested that diet plays a role in ovarian cancer … Continue reading
Johanna’s Law Dear Colleague Update Page
You can check this page to see if your Representative has signed the Dear Colleague letter supporting $10 million in FY 2011 for Johanna’s Law: The Gynecologic Cancer Education and Awareness Act. There are 46 signers — 11 more than … Continue reading
Posted in Blog Leave a comment
The clinicopathological characteristics of ‘triple-negative’ epithelial ovarian cancer
Background ‘Triple-negative’ is traditionally used to define a specific subtype of breast cancer with negative oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor-type 2 (HER2) expressions. ER/PR and HER2 testing is also widely used in the … Continue reading
p53 Autoantibodies as Potential Detection and Prognostic Biomarkers in Serous Ovarian Cancer
Background: This study examined the value of serum p53 autoantibodies (p53-AAb) as detection and prognostic biomarkers in ovarian cancer. Methods: p53-AAb were detected by ELISA in sera obtained preoperatively from women undergoing surgery for a pelvic mass. This group included … Continue reading
March Newsletter
Welcome The Ovarian Cancer National Alliance welcomes two new members to our team – Andrea Glazer and Madiha Khan. Andrea Glazer comes to us from the Jewish Council for the Aging where she served as Director of Development. In charge … Continue reading
Posted in Blog, Newsletter Leave a comment
Health Reform Update March 3, 2010
While both Houses of Congress have passed health reform bills, there is no final proposal or definitive plan of action to enact a health reform law at this time. The House and Senate bills are different, which means neither can … Continue reading
